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Background: Substance use during pregnancy and motherhood is both a public health and criminal justice
concern. Negative health consequences associated with substance use impact both the mother and the developing
fetus, and there are ongoing attempts to criminalize substance use during pregnancy that put pregnant substance-
using women at risk of detection, arrest, and punishment. This study explored the experiences of substance-using
mothers as they navigated health and criminal justice consequences and accessed needed resources in the
community.
Methods: In-depth life history interviews were conducted with 30 recently-pregnant women who had used alcohol
or other drugs during their pregnancies. The three-part interview schedule included questions about past and
current substance use, life history, and experiences with criminal justice authorities, child protective services, and
health professionals.
Results: Women’s stories highlighted their strategies for managing their risk of detection by health or criminal
justice authorities, including isolating themselves from others, skipping treatment appointments, or avoiding
treatment altogether. Women described multiple barriers to treatment and healthcare, including a lack of suitable
treatment options and difficulty finding and enrolling in treatment.
Conclusion: The findings suggest that policies that substance-using women find threatening discourage them
from seeking comprehensive medical treatment during their pregnancies. The implications of the findings are
discussed, particularly the need for further expansion of treatment programs and social services to meet the needs
of substance-using women.Background
Pregnant women who misuse substances (alcohol, tobacco,
and prescription and illicit drugs) are positioned at the
nexus of public health and criminal justice intervention.
The impact of their substance use on their personal health
and the health of their fetuses is a public health concern, as
professionals in this field are dedicated to improving ma-
ternal and infant health. In addition, the past three decades
have seen prenatal substance use become a criminal justice
issue as the fetal protectionism movement spurred the
increasing use of criminal sanctions for “deviant” mothers.
Substance-using pregnant women, especially women of
color and women in lower socioeconomic brackets, are
subject to increased surveillance and may face arrest,
prosecution, conviction and/or child removal (Banwell &Correspondence: rebecca_stone@uml.edu
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Figures from the most recently-published report from
the National Survey of Drug Use and Health (Substance
Abuse and Mental Health Services Administration, 2012)
state that, of pregnant women aged 15–44, 9.4% reported
current alcohol use, 2.6% reported binge drinking, and
0.4% reported heavy drinking. Of pregnant women aged
15–44, 17.6% report smoking tobacco in the last month, a
figure that represents a small, nonsignificant increase from
the 2009–2010 and 2008–2009 findings. The percentage
of pregnant women in this age group who report smoking
tobacco in the last month has not changed significantly in
the last decade, while tobacco use among nonpregnant
women in the same age group has decreased slowly but
significantly each year. Of pregnant women aged 15–44,
5% report current illicit drug use, a proportion notn access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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rate of illicit drug use varies widely with the woman’s age.
Teenaged pregnant women have the highest rates of illicit
drug use (15–17, 20.9%), followed by young adult women
(18–25, 8.2%) and adult women (26–44, 2.2%). There are
no reliable nationwide estimates of the annual number
of infants born after prenatal substance exposure. For
example, the CDC website reports that the rate of Fetal
Alcohol Syndrome (FAS) is 0.2-1.5 cases per 1,000 live
births (CDC, 2014), although this estimate appears to be
based on research from the 1990s. A recent study found
the rate of FAS in one Midwestern community to be 6–9
per 1,000 children, and more general Fetal Alcohol
Spectrum Disorder (FASD) as high as 24–48 per 1,000
children (May et al. 2014). Some infants prenatally ex-
posed to opioids exhibit symptoms of Neonatal Abstin-
ence Syndrome (NAS), including hyperirritability and
dysfunction of the nervous system, gastrointestinal tract,
and respiratory system (Finnegan & Kaltenbach, 1992).
Between 2000 and 2009, the incidence of NAS among
hospital-born newborns increased from 1.20 to 3.39 per
1,000 live births per year. Total hospital charges for NAS
during this time period are estimated to have increased
from $190 million to $720 million, adjusted for inflation
(Patrick et al. 2012). While it is possible that some of the
increase in NAS diagnoses could be attributed to growing
recognition of NAS symptoms and increased surveillance
of pregnant women, it appears that prenatal exposure to
substances is a significant public health problem.
Concerns about fetal drug exposure have given rise to
new laws and applications of existing laws that seek to
deter women from using substances during their preg-
nancies and to punish those who do. The enforcement
of these laws raises questions of fetal personhood and
the extent to which the government may regulate preg-
nant women’s bodies. Substance abuse during pregnancy
is considered child abuse under civil child welfare stat-
utes in seventeen states, and in three states (Minnesota,
South Dakota, Wisconsin) it is grounds for civil commit-
ment (Murphy, 2014). 36 states recognize embryos or fe-
tuses as potential victims of crime, although 24 of these
expressly exempt pregnant women from prosecution for
causing injury to their own fetuses (Murphy, 2014). In
many cases, prosecutors have used laws written to target
for child abuse, child neglect, contributing to the delin-
quency of a minor, causing the dependency of a child,
child endangerment, delivery of drugs to a minor, drug
possession, assault with a deadly weapon, manslaughter,
and homicide (Paltrow, 1992) despite, in some cases, the
aforementioned provisions protecting pregnant women
from punishment (Flavin, 2009; Paltrow & Flavin, 2013).
In some states, the protection from prosecution is incom-
plete, e.g. in Arkansas, women are exempt from being
prosecuted for the homicide of their own fetuses, butmay be prosecuted for battery of their fetuses (Murphy,
2014: 865).
In South Carolina, the ruling in Whitner v. State
affirmed the conviction of criminal child neglect for a
mother whose newborn tested positive for cocaine metab-
olites. The South Carolina Supreme Court stated that “the
plain meaning of “child” as used in [the child endanger-
ment statute] includes a viable fetus” (Whitner v. State,
1997). The court reaffirmed its stance on the issue in State
v. McKnight (2003), when it upheld Regina McKnight’s
2001 conviction for homicide by child abuse after her
pregnancy ended in a stillbirth attributed to Knight’s use
of crack cocaine. In 2008, the same court unanimously
ruled that McKnight did not have a fair trial, recognizing
that McKnight’s counsel failed to make use of existing
evidence from “recent studies showing that cocaine is no
more harmful to a fetus than nicotine use, poor nutrition,
lack of prenatal care, or other conditions commonly asso-
ciated with the urban poor” (McKnight v. State, 2008).
McKnight was released from prison after serving more
than eight years (NAPW, 2008). McKnight’s case is similar
to the ongoing case of Rennie Gibbs of Mississippi, who
was indicted in 2007 for “depraved heart murder” when
she delivered a stillborn daughter whose blood showed
traces of a cocaine byproduct. Gibbs was only 16 at the
time. Experts who later examined the autopsy reports
concluded that the more likely cause of death was umbil-
ical cord compression. Murder charges against Gibbs were
dropped in April, 2014, after more than seven years of
legal entanglements. Charges were dismissed without
prejudice, leaving the possibility for charges to be refiled
(Fowler, 2014).
In 2013, Alabama became the second state to explicitly
allow pregnant women who use drugs to be charged
with criminal child abuse when the Supreme Court of
Alabama held that a viable fetus is considered a “child”
for the purposes of the state’s criminal statute prohibiting
the chemical endangerment of a child (Murphy, 2014:
862). Most recently, in April, 2014, Tennessee became the
first state to explicitly criminalize drug use during preg-
nancy through legislation. Governor Bill Haslam signed
SB1391 into law in April, 2014, amending Tennessee’s
fetal homicide law to allow women to be prosecuted for
the use of narcotics while pregnant. The law allows
women to be charged with aggravated assault, which
carries a penalty of up to 15 years in prison (TN
SB1391, 2014).
It is difficult to produce an accurate count of the num-
ber of such cases, as there multiple barriers to the full
identification and documentation of cases that, for ex-
ample, do not result in published court opinions and do
not receive public attention. The most recent estimate
comes from the work of Lynn Paltrow, Jeanne Flavin, and
the National Advocates for Pregnant Women. Paltrow
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which pregnancy was “a necessary factor leading to
attempted and actual deprivations of a woman’s physical
liberty” (2013: 299). Illicit drug use was mentioned in 348
(84%) of these cases. This record also notes the geographic
distribution of cases and the sociodemographic status of
the defendants, finding that the largest percentage of cases
originate in the South (56%), followed by the Midwest
(22%). 59% of the cases involved women of color, and
women were represented by indigent defense in 71% of
cases. These figures support the argument that punitive
policies regarding substance use during pregnancy are
disproportionately enforced against poor women and
women of color.
The authors believe that this work is a “substantial
undercount” (Paltrow & Flavin, 2013: 304), noting that
the lack of searchable databases of cases, the confidenti-
ality of family and juvenile court proceedings and civil
commitment proceedings, the lack of media coverage of
hospital detentions and compelled treatment, and lack
of access to court records from Native American tribal
courts. The record is also unfortunately out of date by
almost a decade and, as the above-mentioned cases,
court decisions, and legislative acts demonstrate, the ar-
rests and prosecutions of pregnant and substance-using
women continue. A very recent New York Times opinion
piece by Paltrow and Flavin (2014) updates the record,
stating that “since 2005, we have identified an additional
380 cases.” The arrest and prosecution of pregnant
women persists despite extraordinary consensus by public
health and medical associations that such actions under-
mine attempts to improve maternal and infant health (e.g.,
American College of Obstetricians and Gynecologists,
2011; National Perinatal Association, 2011; American
Psychiatric Association, 2001; American Nurses Associ-
ation, 1991; American Academy of Pediatrics, 1990;
March of Dimes, 1990; National Council on Alcoholism
and Drug Dependence, 1990).
In some places, e.g. Tennessee, women charged with
substance use during pregnancy may be allowed to use
evidence of finding and attending treatment as an affirma-
tive defense. However, pregnant women seeking substance
use treatment may find that there are no suitable treat-
ment programs available. For example, Tennessee SB 1391
allows women who give birth to substance-exposed in-
fants to avoid charges by successfully completing a court-
approved treatment program, but it is yet unknown what
will be “court-approved” and what counts as “completing”
a program. Specialists are concerned that methadone
treatment and other opiate replacement therapies, con-
sidered the gold standard for managing opioid addic-
tions, will not be accepted by the courts. Furthermore,
the bill did not create any new treatment options, ex-
pand existing options, or provide additional funds tocare for patients (Beyerstein, 2014). Journalists from
“America Tonight” contacted every treatment program
listed on the Tennessee Department of Health and
Human Services website that claimed to treat pregnant
women and found five clinics that would allow pregnant
women to enroll in their program and accepted Medicaid.
Two of the programs were full, leaving fewer than 50 beds
available (Dosani, 2014).
In the late 1990s hospital staff at the Medical University
of South Carolina (MUSC) worked with police to
search pregnant patients for evidence of drug use and
facilitate in-hospital arrests. Proponents of this policy
claimed that the goal was to get women into treatment
because they would not go voluntarily. At the time, not
a single drug treatment program in the state provided
services for pregnant and parenting women (Paltrow,
2002: x). Furthermore, in spite of the claim that drug-
exposed children were severely harmed (and thus the
justification for punishment of drug-using women), no
program to treat or monitor the children existed (Paltrow
et al. 2000).
Contrary to claims that arresting and prosecuting
pregnant women will encourage them to desist from
substance use and thus improve maternal and fetal
health, fear of detection and punishment presents a
significant barrier to care for mothers and pregnant
women. Women have reported that they delayed or
avoided prenatal care altogether out of fear of punishment
(Murphy & Rosenbaum, 1999; Poland et al. 1993; Roberts
& Nuru-Jeter, 2010; Roberts & Pies, 2010). The effect of
stigmatization, discrimination and fear of punishment
present a barrier to wanted care. This creates a health risk,
since substance-using women who do receive prenatal
care experience more positive birth outcomes and have
greater opportunities for other health promoting interven-
tions than women who do not receive care (Berenson
et al. 1996; El-Mohandes et al., 2003; Green et al. 1979;
MacGregor et al. 1989; Racine et al. 1993; Richardson
et al. 1999). The burden of these policies falls dispropor-
tionately on poor women and women of color, as those
who use public health and social services are subject to
increased surveillance and heightened risk of being tested
and reported to criminal justice authorities (Chasnoff
et al. 1990; Paltrow & Flavin, 2013; Roberts, 1991, 1999;
Woliver, 2002). Women who can afford private physicians
and avoid public services are likely better able to avoid
testing, detection, and reporting. The probable conse-
quence of this disparity is a widening of the health
inequality across class and race divisions.
The purpose of this study is to gain a greater understand
of the way substance-using women navigate the health
and justice systems in order to avoid criminal justice con-
sequences and to access needed health and social support
resources. In-depth interviews with recently pregnant
Table 1 Description of sample (N = 30)
Variable Mean/% (n) [Range]
Age 28.5 [19–41]
Number of children 2.8 [1–8]
Race/Ethnicity
White 50.0% (15)
African American 26.7% (8)
Hispanic 6.6% (2)




Health Plan 13.3% (4)
Medicaid 56.7% (17)
Private Insurance 16.7% (5)
Education
Less than high school 23.3% (7)
GED 20.0% (6)
High school graduate 26.7% (8)
Some college 16.7% (5)
College + 13.3% (4)
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were pregnant highlight women’s strategies for avoiding
being identified as substance-users and their efforts to
access substance use treatment programs. The results
identify the ways in which fear and stigma create
barriers to care and result in unmet needs for this
population.
Method
The current study uses qualitative methodology to provide
rich description of women’s experiences in their own
words. A loosely-structured interview schedule of open-
ended questions helped to guide the conversation through
the topics of identity, health behaviors and barriers to care.
Participants were encouraged to tell their stories using
their own words and narrative styles.
The target population for this study was women who
were pregnant or recently pregnant (within the last twelve
months) and who had used alcohol, tobacco, illicit drugs,
or misused prescription or over-the-counter medications
at any time during their most recent pregnancies. The
targeted sample size was 30 women. The participants were
selected through purposive sampling with the goal of
sampling a wide range of women with different sociode-
mographic characteristics and substance use histories
(Kerlinger & Lee, 2000; Patton, 2002). As a result, the
sample is not representative of any general population,
but is selected for the purpose of generating “theoretical
jumping off points” (Thompson, 1999). The sample was
drawn from a post-industrial Midwestern city with a
population of approximately 100,000 residents.
Recruitment flyers were posted in the maternity wards
of local hospitals and at drug treatment centers, commu-
nity centers and service enrollment offices. Flyers posted
at local transportation hubs (e.g., the central bus station)
were especially productive. Examples of other recruit-
ment locations included bathrooms at the local library,
pregnancy support clinics, obstetricians’ and pediatri-
cians’ offices, and substance abuse support group meet-
ing locations. Women who completed interviews were
also invited to refer others to the study. In fact, invita-
tion was not usually necessary; women volunteered to
pass along recruitment materials to other women they
knew might like to participate. These recruitment strat-
egies proved highly effective and all 30 interviews were
completed during a five-week period. Due to the broad
scope of the recruitment criteria, very few women were
turned away. Those who were did not meet the criteria
(e.g., had not used substances during their pregnancies)
or represented recruitment targets that had already
been satisfied by previous participants. Interviews were
completed in a single session in a place where women
felt comfortable. At the end of the interview, women
received a $50 VISA giftcard.The sample consists of 30 women between the ages of
19 and 41 (Table 1). The mean age is 28.5 years old.
Slightly more than half the women in the sample self-
identified their race or ethnicity as White (n = 16, 53.3%).
Eight women in the sample self-identified as Black or
African-American (n = 8, 26.7%), one woman identified as
Hispanic (3.3%) and one woman as Native American
(3.3%). Four women in the sample self-identified as
“other” (13.3%). Two of these women were of mixed race,
one woman was adopted and did not know the races of
her parents, and the fourth preferred not to answer.
The criteria for participation in the study included being
currently pregnant or having recently (within the past
12 months) given birth. The current pregnancy or recent
birth did not have to be the participant’s first child. The
number of born children per participant ranged from one
to eight x ¼ 2:8ð Þ.
In the three months prior to discovery of the most
recent pregnancy, the most common substance used was
tobacco (n = 26, 86.7%). Alcohol (n = 18, 60.0%), marijuana
(n = 17, 56.7%) and prescription medications (n = 16,
53.3%) were also very commonly used. Of the 16 women
who reported misusing prescription medications in this
time period, 12 (75% of prescription medication users)
reported using opioid analgesics like Vicodin, Percocet,
Dilaudid, Fentanyl and Lortab. Six women (37.5% of pre-
scription medication users) reported misuse of prescrip-
tion benzodiazepines. The most common benzodiazepines
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usually referred to the drug by its brand name or with the
catch-all “benzos”.
Less common were other substances including cocaine,
methamphetamine, heroin and hallucinogens. These sub-
stances were far more likely to appear in women’s lifetime
histories of substance use than to be mentioned in the
three months prior to the most recent pregnancy. For
example, 14 (46.7%) women reported lifetime use of
hallucinogens, but only two (6.7%) women reported
using hallucinogens three months prior to discovering
their recent pregnancies.Results
The interview recordings were manually transcribed
and coded for the themes of detection-avoidance
strategies and experiences accessing treatment. Several
common strategies and experiences were identified.
Women reported feeling fear of being identified as
substance-users by medical professionals or other
authorities and discussed their strategies for avoiding
detection. They described how they felt that others’
perceptions of them as substance-users had influenced
the type of medical care they received. Finally, women
talked about their experiences of seeking treatment for
their substance use, the barriers they encountered, and
which types of treatment were most effective for them
and why.Fear of detection
Twenty-two women (73.3%) reported that during their
pregnancies they had been afraid of being identified as
substance-users. The scenarios of which they were
most afraid were testing positive for substances at
prenatal visits or after delivery, losing custody of their
newborns and/or their older children, and experien-
cing criminal justice consequences for their substance
use.
The remaining eight women (26.7%) in the sample
reported that they were not afraid of detection. For
most of these women, this was because they were not
using illegal substances. Though they recognized the
harmful effects of alcohol and tobacco, they were not
worried about being tested, having positive test results,
losing their children or being arrested. Women who
were using illegal substances but were not afraid of
being detected said that they felt they had their sub-
stance use “under control” and that they could avoid
detection. Some women were simply unaware that they
might be tested at prenatal visits or at the hospital and
that they could lose their children. For example, when
asked if she had feared coming into contact with the
police or Child Protective Services (CPS), Brittany saidthat it hadn’t really occurred to her to be afraid until it
was too late:
Interviewer: Did you have any concerns about CPS
taking the children?
Brittany: I guess I would say no, only because
nothing like that had happened before. So I hadn’t
seen it and I never really knew anybody who it had
happened to, either, so it really almost didn’t even
seem like a possibility, I mean. That’s why there’s kind
of like a lot of like, that feeling, like the CPS thing
‘cause like I said I never knew anyone really before
that it had happened to, so there’s nobody I can relate
with or, you know, hear about how it went or it
worked out with them or anything like that, so.
Brittany had permanently lost custody of her three
boys. She had managed to keep her opioid addiction a
secret for many years until it spiraled out of control. She
spoke about how her addiction had never resulted in
contact with the police because it was her boyfriend who
would take risks and go out to buy their heroin. “So I
guess I was kinda sheltered in that way,” she reflected,
“We were a using couple, so I guess that’s different than
doing it yourself”.
Women who were using illegal substances and did not
feel afraid of being identified as substance users were the
exception. Pregnancy was a time of great uncertainty for
most of the women, and this was compounded by the
threat of detection. This was especially true for women
who did not know what to expect at prenatal appoint-
ments or delivery. Some women believed they were
drug-tested at every prenatal visit and that every baby
delivered at the hospital had his or her meconium tested
for drugs. Other women felt that the decision to test
mothers and babies was on a case-by-case basis. Others
thought that babies could not be drug-tested without the
parents’ permission.
Denise: I didn’t find out about it until after I asked
my doctor, and that was because all my friends were
saying “Oh, you need to stop smoking pot, you need
to stop doing this, da-da-da-da-da.” And I was like,
wait a minute, I walked in my doctor and I asked him,
“When the baby’s born, are you doing to test me? Are
you going to test me and the baby?” “No, we’re not
gonna test you unless you drop dirty at your visits.”
And I was like, so wait, when you make us pee in the
little jar every time….
Interviewer: It’s a drug test every time?
Denise: Yes, that’s a drug test every time. And that’s
because it’s CPS’s way of knowing if you’re doing
drugs beforehand, they’re gonna take that baby
instantly from you. It’s only for the hardcore drugs.
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Sarah: I don’t know. I would imagine it’s every baby.
Because I don’t know why they would single-handedly
pick out me, maybe because my knuckles are tattooed
[laughs]. Well, I mean, [my husband]’s got track
marks, you know, they might have saw that and
thought that maybe I was doing it, too.
Others were uncertain about the “rules,” like which
substances could be detected, which would trigger CPS
involvement, and how far back into the pregnancy a
meconium test could detect substance use.
Vicki: Well, ‘cause my friend Karen says now is a
good time to quit cold turkey, because they do
check—Sparrow does check the umbilical cord, and…
her baby had—but she had different, she had an
addiction, like my friend Jamie, like to heroin, but
she said if there’s like a certain time limit that if you
stop, it won’t show up in your system or whatever.
It’s like… see, I didn’t—I don’t know anything
about that.
Some uncertainty may be attributable to variation in
testing and reporting policies between different obstetric
clinics and hospitals. Medical organizations have some
discretion in their policy decisions, although they are of
course subject to federal and state laws and administrative
codes. At the federal level, hospitals must comply with the
Keeping Children Safe Act of 2003, which added require-
ments to the Child Abuse and Treatment Act. Under the
act, states are required to develop procedures requiring
healthcare providers to notify CPS if they suspect a child
has been subjected to drugs, or is suffering from with-
drawal symptoms at birth.
Individual clinics and hospitals likely have varying in-
ternal policies regarding what is to be detected through
urinalysis, along with other testing and reporting proce-
dures. It is unlikely that most women are aware of the
numerous federal and state laws and policies. Inquiring
about the drug testing policies at a clinic or hospital may
increase staff ’s suspicion of one’s substance use habits
and is unlikely to be of much use, as most women in this
study had no choice in the clinic they attended or where
they delivered their babies.
Strategies for avoiding detection
To manage the risk and uncertainty of being identified
as a substance-using pregnant woman, women in this
study adopted various strategies. Some strategies seemed
pro-social and pro-health, like being honest with medical
practitioners or seeking out treatment. Other strategies
seemed more damaging, like isolating oneself from friends
and family who might detect the substance use, hiding ordenying the pregnancy, timing prenatal appointments so
that persistent substance use would not show up in drug
tests, skipping some prenatal visits or avoiding prenatal
care altogether.
Honesty
Six women (27.3%) adhered to the idiom that honesty is
the best policy and were up-front with medical practi-
tioners. They felt that being honest showed that they
were good mothers despite their substance use and they
hoped that doctors and nurses would appreciate their
honesty and affirm their motherhood identities:
Interviewer: Are you worried about them drug-
testing you or anything like that?
Vicki: [emphatic] Yeah. [nervous laugh].
Interviewer: Do you still go [to your appointments]?
Vicki: Yeah. That’s why I still go, because I want to
show them I’m not a big time drug user — if
something does happen, I’m not a big-time drug user
and… I do care about myself and I do care about the
baby’s health, you know. I have a friend who has a
baby due any day, or in a week or so, and she hasn’t
had no prenatal care through her whole pregnancy.
Kim: I mean, I was honest, and I think that’s the best
thing, so I was able to tell them “Look, I did smoke
marijuana and I didn’t know that I was pregnant,
and I’m not addicted, and is there anything you can
give me to where it would be out of my system or
anything you can tell me about the effects on being
pregnant?” I asked for information, and I think a lot
of those people respect you a little more, as to where
there won’t be so much concern, because if you’re
hiding it and they see it right in your levels, especially
being pregnant, there’s going to be some concern and
they’re going to go behind your back and call CPS.
With me being so blunt, so open and wanting the
help, I think it shied a lot of people away from being
so concerned or disturbed.
In these excerpts from interviews with Vicki, a meth-
amphetamine user, and Kim, who was using alcohol and
marijuana, both women express their hope that being
up-front with doctors would help them be perceived as
good mothers who were concerned about the health of
their fetuses, resisting the master narrative of substance-
using mothers who are selfish and unconcerned. Vicki
was pregnant at the time of her interview and was yet to
see if her strategy would be successful. Kim had stopped
smoking marijuana before the birth of her daughter and
was only using alcohol (albeit heavily), so she did not
have any contact with CPS.
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strategy to be honest with their doctors. Melinda had been
honest with her doctors about her opioid and benzodi-
azepine use but felt that this strategy had not worked for
her, because she was unhappy about how long her son
had to stay in the nursery before he could come home
with her:
Melinda: I would never advise somebody to have a
child [at the hospital]. I thought I was helping my
child by being honest during my pregnancy, I thought
I was helping him if I was honest with my doctors.
No, I wasn’t. All I did was damage that relationship
and our early bonding by letting them have that “in”
to keep him from us. We could’ve, and we would
have, taken better care of him than what they did,
leaving him in his bassinet with a million other
babies in there and not enough people to take care
of all the babies.
The risk of being honest may be lower when women
are using legal or socially-accepted substances or when a
woman has a trusting relationship with her medical
provider. The relationship between a woman and her
medical provider might be one way that socioeconomic
status grants some substance-using women privileges and
health benefits. If a woman has health insurance and a
private doctor with whom she has a long history,
honesty may be a safe strategy that allows her to receive
support and treatment specific to her risk status. If, in
contrast, a woman must rely on a public health clinic
that she can attend only when pregnant and where she
may see a different doctor every time, she may not know
the doctor or the practice’s drug testing and reporting
policies and will not have the opportunity to develop a
trusting relationship with the practitioner. In this case,
revealing one’s identity as a substance-user seems a
more risky strategy, because the outcome is more
uncertain. These possibilities suggest an area in need of
further research.
Social isolation and denial of pregnancy
Another set of strategies women employed was to keep
to themselves, avoiding friends and family who might re-
port them to CPS. For two women, this went as far as
concealing or denying their pregnancies:
Interviewer: Did you do anything to try and hide it or
avoid getting caught?
Kim: Yes, I did, I did, um, to hide the pregnancy, I
denied that I was pregnant. I drank as if I wasn’t
pregnant, and I denied some more, I kept denying.
And I lied, a lot.Of course, pregnancies are typically only concealable
for a limited amount of time. Another strategy for women
was to socially isolate themselves from anyone who might
report them to CPS:
Interviewer: Did [fear of detection] stop you from
doing anything you might’ve otherwise wanted to do,
like stop you from doing something you wanted
because you were worried?
Alice: Yes, yes. I had stopped talking to everyone,
period, because I didn’t want the wrong person to go
over there and say something. I didn’t want them to
go do that and I didn’t know who to trust, so I wasn’t
saying anything.
The strategy of avoiding people may be based on
women’s past experiences with CPS. Of twenty-two
women who reported having past contact with CPS, the
most commonly mentioned source of contact (n = 10,
45.5%) was a report to CPS by a third party. These third
parties included roommates and friends, family mem-
bers, ex-partners, and neighbors. Some of these reports
were made out of concern for the children, but many
reports were identified by the women as acts of retaliation.
For example, a mother would get into an argument with
another woman and that woman would report her to CPS
in retaliation. In another case, a mother broke up with her
abusive boyfriend and, in retaliation, he called CPS and
told them she was pregnant and smoking marijuana.
Other women had family members who wanted custody
of their children and would call CPS very frequently,
forcing CPS to investigate every time even though they
had found time and time again that the children were
happy and healthy. In light of these experiences, women
may feel that isolating themselves is an effective strategy
for avoiding contact with CPS and law enforcement.
Avoiding medical care
The most common strategy employed by women afraid of
detection was avoidance of medical care (n = 12, 54.5%).
This strategy included scheduling visits around their
substance use so that any tests would come up negative,
skipping some visits, or avoiding prenatal care altogether.
Women who used substances that are only detectable
through urinalysis for several days after use were able to
schedule their appointments around their substance use.
Interviewer: And during this time, while you were
pregnant, were you ever worried that if you went to a
doctor, they would drug test you?
Sarah: Kind of, yeah. Kind of. But that was only a
couple of days after I did the heroin. But I would
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you know, that stuff lasts in your system for three to
four days, so I would make sure not to do it around the
time of the appointment, just to be on the safe side.
Denise: I drank a lot of water. I always made sure
that I stopped certain stuff before I went in. I had it
already charted out for how long it took to get out of
my system, this, that and third, like, I made sure I had
my stuff on lock. It’s the good thing about being able
to make your appointments before you go in.
Some women, like Denise and Amelia, seemed proud
of their ability to avoid detection. Amelia laughed, “A
lot of people think drugs are dumb or hippies are stupid,
but it’s some hard work, man, it’s like chemistry”.
Women would “chart out” on a calendar the days that
they used and how long it would be before they would
test clean and then schedule medical appointments
accordingly. By doing so, they were able to avoid
positive prenatal drug tests. This method is not effective
for avoiding detection at delivery, though, because
meconium begins to form in the second trimester of
pregnancy and a positive test can indicate substance use
a month or longer prior to delivery (Farst et al. 2011).
This is an important consideration if meconium testing
is triggered only by positive prenatal tests, as women
who use substances that pass quickly through the body
may successfully evade detection at prenatal appoint-
ments and also at delivery. This strategy is less effective
if women deliver at a hospital that tests all mothers
and/or babies or makes decisions about testing based
on other factors, like late prenatal care or the mother’s
appearance, demeanor, or history of involvement with
CPS.
Women also reported skipping appointments if they
had used recently or avoiding care altogether:
Suzanne: I wouldn’t go to the doctor’s. I would skip
appointments and things, and stretch them out. I
always went because, again, CPS will get involved if
you don’t go to the doctor’s, so you still have to go,
but you know, you didn’t—you just have to stretch it
out or go late or delay it or whatever.
Interviewer: And did worrying about being involved
with CPS or getting her taken away, did it keep you
from doing anything you might otherwise do?
Elsie: I just didn’t go.
Interviewer: Didn’t go to the doctor?
Elsie: Yeah. I just wouldn’t show up, I was so scared.Alice: My third child, I had no prenatal care.
Interviewer: For what reason?
Alice: Because I was taking drugs, well, not drugs-
drugs, I was down there smoking on marijuana and
drinking liquor. And they told me if they see THC or
something like that in my system, then protective
services would get involved. So I didn’t go to no care
for her, none.
Research repeatedly demonstrates that substance-using
women who receive prenatal care experience more posi-
tive birth outcomes and have greater opportunities for
other health promoting interventions than women who
do not receive care (Berenson et al. 1996; El-Mohandes
et al., 2003; Green et al. 1979; MacGregor et al. 1989;
Racine et al. 1993; Richardson et al. 1999). Prenatal care
appointments provide practitioners the opportunity to
connect women to needed resources, to screen them for
dangerous illnesses or injuries, to screen for intimate part-
ner abuse victimization, and to implement many other
public health interventions. By adopting policies that scare
women away from treatment, clinics and health organiza-
tions lose the opportunity to intervene and promote
maternal and infant health.Substance abuse treatment experiences
Twenty women (66.7%) had sought substance abuse
treatment at some point in the past and had navigated
barriers to finding, affording and attending different
types of treatment programs. Of the ten women who
had not sought treatment, most used only alcohol,
tobacco, and/or marijuana. Two of these ten women
used methamphetamine, one used assorted prescription
pills, and a fourth used hallucinogens.
The twenty women who had experience with substance
abuse treatment had explored a variety of different pro-
grams, from short-term detox and outpatient support
groups to residential treatment and long-term methadone
maintenance. Each program type came with its own limi-
tations and barriers to entry.Detox
Three women had sought out treatment facilities that
would allow them to detox (most commonly from opi-
oids). These programs were very short-term, usually less
than a week, and offered medically-assisted or unmedi-
cated detox. Women were in agreement that unmedicated
detox was an awful experience and that they would only
stay at places that would give them medication to help
with their withdrawal symptoms. At some places, such
medication was promised but not delivered:
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center] was awful. I wouldn't send my dog there. I
went there during the day and the lady was really
nice. “Oh we'll help you, we'll give you something to
ease the withdrawal and help you sleep and we'll keep
you comfortable.” I'm like okay, this is what I need,
this is where I need to be. And that night, they refused
to give me anything to help with the withdrawals and I
was freaking out and I was sick and I had just had it.
Two o'clock in the morning, I ended up walking out of
there. They wouldn't help, they just basically looked at
me like I was some horrible drug addict.
Interviewer: So you walked out of there?
Tasha: Mmhmm [yes], gave up on that and went right
back to using.
Even if Tasha had stayed and detoxed, such programs
frequently offer little in the way of aftercare unless they are
paired with residential or outpatient counseling. Women
who had detoxed, with or without medical assistance, re-
ported that the process did nothing to address the triggers
for their substance use. They spent up to a week in detox
but then returned to the same environment and same
social setting they had been in when they were using.
A problem with detox is that it is rarely a possibility for
women who are already pregnant. Though the physical
withdrawal symptoms are unpleasant for adults, they can
be lethal for the fetus. For substance-dependent women
who wanted to continue their pregnancies, withdrawal
was a dangerous choice, and few medical professionals
would agree to supervise the process. Kellie found out that
she was pregnant and didn’t want to start taking metha-
done, so she tried to find a treatment center or a hospital
where she could be monitored while she went through
withdrawal from heroin. She couldn’t find anyone who
would help her:
Kellie: It was just the whole, I guess liability issue of
the miscarriage associated with treatment and
withdrawal of the pregnancy that really scared people.
And even when I went to [the local hospital] and said
“Can you guys watch me while I detox?” and they said
no, I mean, I even—and then they ended up sending
me home, and I was like “I’m sick, can you at least
send me home with some Vicodin or something?” and
they were like, no, so I said “So you’re going to send
me home to have a miscarriage, then?” and they
ended up writing me, like 10 Vicodin or something.
According to Kellie’s understanding, the medical staff
did not want to monitor her withdrawal for fear they
would be liable if anything happened to her fetus. Instead,they gave her more opioids to stave off the withdrawal
and then turned her away. Kellie continued to use heroin
while seeking out other treatment possibilities.
Opioid replacement therapy
Opioid replacement therapy is the practice of replacing
illegal opioids with longer-acting opioids like methadone
or buprenorphine administered under medical supervision.
Methadone emerged as a treatment solution for heroin
addiction in the 1960s. Methadone maintenance therapy
spread quickly and became the gold standard for treatment
of opioid dependence, “probably the most evaluated form
of treatment in the field of drug abuse treatment” (Farrell
et al. 1994: 997). It is recognized as the most effective treat-
ment for heroin addiction according to reviews by the
Institute of Medicine (1995) and the National Institutes of
Health (1998).
Despite such robust evidence of the benefits of metha-
done maintenance therapy, it remains, for some, a highly
controversial practice. Since their beginning, methadone
programs have been accused of merely substituting one
drug for another (Joseph et al. 2000). Methadone mainten-
ance programs have been cited as an example of evidence-
based medical programs that have been adversely impacted
by misperceptions and biases, limiting their implementa-
tion and reach (Gordis, 1991). As a result, patients fear that
the stigma associated with being a methadone user will
negatively impact their jobs, their social relationships
and the medical care they receive (Joseph, 1995). Stigma
and discrimination appear to be powerful forces prevent-
ing the full acceptance of methadone treatment, and likely
impacts both pregnant and non-pregnant women seeking
treatment.
The controversy surrounding methadone maintenance
was demonstrated by women in the current study. Eleven
women had, at some point in their lives, sought opioid
replacement therapy with methadone or buprenorphine,
another partial opioid agonist more recently approved for
opioid addiction treatment and known by common
product names like Suboxone and Subutex (FDA, 2013).
Although most women were overwhelmingly in favor of
opioid replacement therapy, many of the same women
were concerned about never being able to stop taking
methadone.
Alyssa: I would honestly say it’s the day I got on
methadone, because it totally, has totally changed my
life, because as an adult, you know, I really didn’t lead
the greatest lifestyle up until the last two years, and
prior to that I don’t have any good memories, so. […]
I had a lot of people say “Methadone’s like liquid
handcuffs.” You still have to get it every day. I look at
it as you’re not going out and getting into trouble, but
some people still look at it as you have to have it, and
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a… you know, now I look at it different, I’m glad it
was there to change my life.
Others were less effusively appreciative of methadone
treatment but still felt that they could not have achieved
sobriety without it:
Eleanor: I needed something – no. I mean, I wish I
didn’t need, didn’t need to get on the methadone, I
wish that I would’ve been able to do it the other way,
you know, without any medication, but no, I wouldn’t
say it makes me weak. I would just—you know, I didn’t
need some help, but when I got on it, I was able to do
it. Because there are some people on methadone that
still use, and continue to use, and even that doesn’t…
doesn’t help them. So you know, with a little help I was
able to pretty much beat my addiction.
Most women shared similar experiences, but two women
expressed a strong dislike for methadone maintenance.
One woman called methadone “liquid handcuffs,” because
she felt that once someone started taking methadone, they
would be on it for life. Naomi explicitly described many of
the arguments made against opioid replacement. She had
recently used Suboxone (buprenorphine) to recover from
her dependence on opioid painkillers but had made a point
to wean herself from it quickly thereafter:
Naomi: I went to [a residential treatment facility]
and… I forgot what they gave me, it wasn’t
methadone… Suboxone.
Interviewer: Suboxone?
Naomi: Yep. And I got Suboxone, and I’ve been clean
since.
Interviewer: So you got the Suboxone at [treatment
facility]?
Naomi: Yep. I was in their detox facility for three
days, and then I went into their residential program.
Interviewer: Are you still on the Suboxone?
Naomi: Nope. I think [Suboxone maintenance] is
retarded [laughs]. All it is is a legal way for you to get
high. Most people abuse it, they don’t take it the way
they’re supposed to. […] You’re still getting high, and
you’re not going through withdrawal. All it is is a
state-funded way for you to get high. Now the state’s
paying for your way to get high, and that’s the way I
feel about methadone.Women on maintenance programs were aware of these
perceptions of their treatment programs and explained
why “substituting” opioids was so successful:
Loretta: And people are all “Well, you’re substituting
for another drug” and da-dada-dada, well, the reason
why it works is because it’s legal, so you change your
whole lifestyle. Because of the fact of it being legal,
you don’t have to deal with the illegal aspect of taking
it and dealing with all the illegal people and all the
stealing and doing this to get it and doing that to
get it and running around with drugs on you. You
don’t have to do that no more, ‘cause it’s legal, so you
don’t have to be in that whole circle no more, and
you get yourself away from places, people and things,
and it works.
As with other treatment options, women encountered
barriers to enrolling in methadone programs. Interest-
ingly, the barriers they encountered were the opposite of
what one might expect. Women who were pregnant
were able to enroll in programs immediately:
Interviewer: How was your experience trying to get
into [the methadone clinic]?
Cora: It was really easy, because I was pregnant, so I
got on the same day. But if I wasn’t pregnant then it
takes a couple weeks, so you have to use, and so on
and so forth.
Women who sought out methadone maintenance treat-
ment when they were pregnant had no difficulty enrolling
in a clinic. Women who were not pregnant when seeking
treatment were not so successful. Brittany had unsuccess-
fully sought methadone treatment after the birth of her
second son and had not been able to overcome the bar-
riers she encountered. She continued to use and became
pregnant again, and finally lost custody of all three of
her children.
Brittany: I think, I think the program has changed a
lot, though, honestly, because in between the time
when I – after I had [my second son], like a couple of
months, we really briefly tried looking into going to
another one at that time… I don’t know if like the
requirements changed or something, but it was, it was
a different point, too, though, but it was a lot more
running around and we never ended up going through
with it. ‘Cause it was like, well, first they wanted us to
go see a doctor, and they wouldn’t take our insurance,
because they wanted us to take a heart test first… and
then it was just like, so much drama with that that we
never ended up going through with it.
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Brittany: Yeah, like I said, I don’t know if the
requirements changed, ‘cause it was a couple of years
before when I started coming to this one and it was a
different clinic, too, so maybe they had different
requirements, but it was where it was so ridiculous in
the end that we didn’t go through with it, whereas
with this one, if you have your money for the week,
you show up that day and you’re basically starting
that day. Whereas the other one it was different, it
was like they wanted us to wait a couple of weeks in
between, you know. And you have like a fleeting
moment between when you have the money in your
hand and you wanna start [treatment and] when you
start shutting down, so…
Once enrolled in methadone programs, women
were concerned about continuing to pay their bills.
Women who were pregnant or who had recently given
birth were eligible for Medicaid, which would cover
the cost of treatment, but they worried about what
would happen to them once they no longer had
insurance:
Alyssa: With the methadone, I do have my Medicaid
that pays for it, and I do sometimes worry like, “What
if that gets cut off?” Because it’s expensive. But I
would just have to find – I would have to find a way
to pay for it. But, I mean, it’s… the community has
been pretty good in helping find, you know, helping
me find the help that I need to get clean.
Other women were cobbling together some Medicaid
allowances and assorted grants, but were facing the
possibility of being rapidly tapered off methadone if they
could not afford to continue paying for it:
Melinda: I got a grant to go to [a treatment program],
grant funding, and then I somehow got Medicaid to
help with the methadone treatment, however, that
may be in jeopardy, and if they’re not going to pay for
it, I’m gonna have to get off of it a lot faster than
would be healthy, and I’m scared. […] I’m just gonna
be screwed, and then there’s gonna be no way out
unless I use heroin or something to survive. I don’t
know. I’m scared of that possibility.
Finally, women who did take methadone during their
pregnancies felt that there was insufficient information
about what they should expect at the hospital and when
they brought their infants home. Methadone has been
deemed safe for use during pregnancy but can still pro-
duce symptoms of withdrawal in exposed infants. Somewomen were surprised at the severity of their infants’
withdrawal symptoms:
Alyssa: But man, having my daughter, being on
methadone, I know it changed my life, but shoot, I
went and got my tubes tied. That’s how much that
methadone—I don’t understand how women can have
child after child on the methadone.
Interviewer: Really? That bad, huh?
Alyssa: Watching my daughter go through it? Yeah,
that bad. It really woke me up, I want to come off
methadone, I’m at that point, you know, yeah. It
wasn’t fair, it wasn’t fair to her. I don’t think my
doctors were 100% honest, you know, I was already on
the methadone when I got pregnant, so there was
absolutely nothing I could do, but, you know, they
sugar-coated it. We were in the hospital five weeks, she
was on a very high dose of morphine, and she had to be
on phenobarbital and just, it sucked. And still, if you
get loud and go up to her, you’ll startle her, and she’s
just now getting on a normal sleeping pattern and, yeah,
it’s hard thing—it’s hard to watch your child go through
that, knowing it’s something you did, you know.
Others were unprepared for how they would be treated
at the hospital. In some cases, they were informed by med-
ical personnel that CPS was called for all mothers using
methadone, whether it was prescribed or not. Others re-
ported that CPS was mistakenly called. Kellie felt trapped
by hospital policies about methadone use, as she thought
that enrolling in the methadone clinic would help her
escape involvement with CPS:
Kellie: I guess I feel kind of confused as to, they tell
you [methadone treatment]’s your only option yet it’s
considered so questionable or harmful that they have
to call CPS, it’s required for your baby and stuff.
Kellie had used other opioids and marijuana through-
out her pregnancy, so it is possible that CPS was called
because of the presence of those substances in her son’s
meconium and that she misunderstood the hospital’s
policy. However, she was not the only woman confused
about, on the one hand, methadone as a prescribed
treatment and, on the other, its role in their newborns’
withdrawal symptoms and their involvement with CPS.
The confusion was shared by other women in the study
and by the public health nurses with the county health
department’s Family Outreach Services, who were in the
process of trying to assemble articles and pamphlets
about methadone use during pregnancy so that they can
better prepare the women on their caseloads for their
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borns’ withdrawal symptoms, and soothing their babies
when they go home.
Residential treatment
Fifteen women, half of all women in the study, had
experience with residential or in-patient treatment
programs. These ranged from general “rehabs” to special
programs in prisons. Natalie said that the most effective
treatment she had ever received was an inpatient program
inside a women’s prison. She called it “RSAT,” which may
be one of the Residential Substance Abuse Treatment
programs administered through the Bureau of Justice
Assistance (2012).
Natalie: And the last six months of my prison
sentence I did a program called RSAT and it’s an
inpatient treatment inside the prison […] I went
through all that and I started bringing them emotions
out and digging deep and talking about what I went
through and stuff, I had to look at it and deal with it.
And a lot of that has so much anger in me, anger
towards my mom, towards the court system, towards
everybody that failed me all my life, as a child.
And then, you know, anger at myself with losing
[custody]. Once I dealt with all of that, it really, really
changed who I was inside and it made me stronger.
You would think I had a lot of strength going
through everything I went through, but I just buried
everything under drugs.
Natalie had been in other residential programs before
RSAT and had not found them effective. After leaving
prison, she did return to substance use briefly before
desisting for some time. At the time of her interview,
she reported that she had relapsed for a few months at
the beginning of the current year and became pregnant
at the end of that period, and now she felt that she
would be clean for good.
Hazel had been to a residential treatment program to
help her overcome her addiction to crack cocaine. She
found the classes offered there very helpful, both in their
instruction but also for the social opportunities:
Hazel: Well, the classes helped, too. They had classes in
the rehab, the lifestyle changes class, different classes I
could take. The, um, I say the lifestyles class is the one
that helped me more, because they helped me to prepare
for what the real life was really all about, and beside the
drugs and all that, I was actually somebody else.
Women felt that residential treatment was not effective
if it was too short or there was no outpatient support.
Those women who left residential programs and returnedto substance-using social networks and environments also
returned to substance use. Alyssa recalled finishing three
months in treatment and being picked up at the facility by
her mother, who drove them straight to the “dope house”.
Elizabeth had recently spent two weeks in treatment but
was not optimistic about the future:
Elizabeth: Yeah, but once I left – I just recently left –
once I left, I’m just back out here in the real world.
Interviewer: When were you there?
Elizabeth: I went on the 21st, I think.
Interviewer: Oh, wow, you were just there. So after
release?
Elizabeth: I started back drinking. Haven’t found any
cocaine, or it hasn’t been an urge right now. I’ve
popped Vicodins.
Interviewer: So the real world is not the same as the
treatment world?
Elizabeth: No. Lot of temptation. […] It’s not long
enough, I don’t think so either. It’s not, it’s so not long
enough. It’s like a vacation from the real world.
In interviews with women who had sought residential
treatment during their pregnancies, references to the
same treatment facility repeatedly arose. It became obvi-
ous that women were talking about this single treatment
facility because, to their knowledge, it is the only resi-
dential substance abuse treatment program in the state
that will accept pregnant women.
Kellie: [The nurses at the local hospital] gave me the
list of methadone clinics in the area, there’s a couple,
and some other rehabs in the area, rehab clinics, and I
called all of them on the sheet. None of them would
accept pregnant women unless I was already detoxed
or on a methadone maintenance. None of them would
do a withdrawal while I was pregnant, until I finally
found one place that was in [distant town], it’s called
[name of program]. And they are, as far as I know, the
only place in the state that will take pregnant women
who are, you know, addicted to opiates and have to go
through withdrawal or be put on methadone or
whatnot. But unfortunately I did not find them until I
was probably about seven and a half months along…
The facility women mentioned is located 104 miles
from the study site. At this location, there is an option
for children to stay at the facility with their mothers.
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fied as a barrier to care for substance-using mothers
(Blume, 1990; Center for Substance Abuse Treatment,
1994; Finklestein, 1994; Marsh et al. 2000), but women
in this study reflected that having their children there
was not necessarily helpful:
Cora: Yeah, I went somewhere where I could take my
kids, and I ended up taking my youngest, and she
ended up getting abused by other children in there
that had it way worse than my kids had it. They had
no training at all, they didn’t have contact, they were
almost feral. […] I think it’s the only place in
Michigan. And I don’t really think it should be a
setting—I mean, it’s good for some people, but you
can’t concentrate when you gotta go everywhere with
screaming kids in recovery, you just can’t.
Cora ended up sending her daughter to live with her
daughter’s father, but for women lacking that option, it is
not clear what the solution might be. Cora’s experience
suggests that although allowing children to stay with their
mothers at treatment facilities may reduce barriers to care
for some women, it may reduce treatment effectiveness
for others.
Discussion and conclusions
The current analysis provides an overview of the issues
substance-using mothers encounter when negotiating
prenatal care, hospital delivery, and seeking substance
abuse treatment. Women discussed the strategies they
employed to avoid being detected as substance-users or,
in some cases, explained why they had not feared detec-
tion. Women who used alcohol and tobacco were less
likely to fear being identified by medical professionals or
law enforcement authorities than women who were using
illicit substances. Some women who were using illicit sub-
stances were not afraid because they had no personal or
vicarious experience with the consequences of detection,
particularly loss of custody. Of the women who did fear
detection, some were up-front and honest with their
doctors, and they felt that this would protect them from
the worst consequences because their doctors and nurses
would appreciate their honesty. Others hid or denied their
pregnancies, isolated themselves away from others who
might report them to authorities, and delayed or avoided
prenatal care.
The results suggest that punitive policies have indeed
had some chilling effect on women’s help-seeking behav-
ior by discouraging women from accessing prenatal care
or leading them to skip appointments, and by motivating
women who did attend appointments to withhold medic-
ally relevant information about their substance use. Some
women were honest with medical professionals but thenexperienced poor treatment, making them less likely to be
honest again in the future. Women also shared their expe-
riences accessing substance use treatment. The benefits
and drawbacks of different treatment options were dis-
cussed, as well as the barriers women encountered as they
searched for and received treatment.
These findings demonstrate that women are in need of
more treatment options, better access to the treatment
of their choice, and more support for staying in treat-
ment. The women in this study revealed that in their
searches for residential treatment centers they could
locate only one facility that would accept pregnant women
or women who needed to bring their children with them.
This treatment facility is located more than a hundred
miles from the study site, making transportation and
visitation expensive and time-consuming. Women would
benefit from an increased number of residential care facil-
ities. There are several methadone clinics in the study area
and women who sought treatment there when pregnant
were pleased to find that their status as pregnant women
afford them expedited enrollment in treatment. This is an
excellent policy that should be continued, as most women
spoke positively about their experiences on methadone.
However, when women sought methadone treatment
between pregnancies, they faced waiting periods of days or
weeks. During this delay, women continued to engage in
risky substance use and, in some cases, lost their desire to
enter treatment. Increased funding for methadone treat-
ment clinics to support larger client populations would
help to cut down on these waiting periods and get women
into treatment when they are motivated to enroll. Add-
itionally, increased grant funding to help women stay in
treatment once they are enrolled would help to decrease
women’s anxiety about what will happen if they can no
longer afford to pay for their methadone.
Women’s experiences seeking methadone treatment
also highlighted a need for more information about this
treatment option, both in general and specifically for preg-
nant women. In general, women harbored some miscon-
ceptions about methadone and were unclear about the
treatment process. They were concerned that if they start
taking methadone, they would never be able to stop.
Women who were pregnant and on methadone were not
well-informed about what to expect when their babies
were born. They did not expect to see such severe with-
drawal symptoms, they did not know that CPS would be
called in for hospital and home visits, and they did not
understand the way doctors and nurses assessed their in-
fants’ withdrawal symptoms and administered treatments.
This lack of information left women feeling confused, vul-
nerable and in some cases misled or betrayed by treatment
professionals. Better communication between medical
staff and mothers may help to ease some of this confusion
and reduce feelings of stigmatization and unfair treatment.
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materials to help prepare pregnant women for the ex-
perience of delivering their babies at hospitals, including
what to expect in regard to pain management, infant
withdrawal symptoms, CPS involvement, treatment ap-
proaches for withdrawing infants, and how to work with
doctors and nurses to help the process go smoothly. These
information sessions could also include advice for com-
forting methadone-exposed babies once they come home.
A major implication is that women would benefit from
some sort of wrap-around or comprehensive care and
professional advocacy. The few women in the study who
were working with public health nurses were apprecia-
tive of the way the nurses were available to answer their
questions, help them with transportation to and from ap-
pointments, and help them access resources like car seats,
cribs, baby clothes, and childcare assistance. Expanding
similar programs to increase enrollment and funding sup-
port would likely be of great benefit to women in similar
situations. Public health nurses could be important advo-
cates in court cases, as they can attest to women’s efforts
to desist from substance use and perform their mother-
hood responsibilities. Home-visitation nursing programs
show great return on investment for at-risk populations
(Eckenrode et al. 2010; Karoly et al. 1998; Karoly 2005;
Kitzman et al. 2010; Olds et al. 2010) and benefit not only
the direct recipient, but demonstrate spillover effects for
other families and the community (Karoly 2005). Such
programs should be considered a very strong policy option
for pregnant women and mothers struggling with sub-
stance use.
The findings of this small, exploratory study have im-
portant limitations. The current research presents the
perspectives of substance-using mothers. They expressed
frustration and anger with the system, which included
treatment professions, CPS caseworkers, judges, attorneys,
social service providers and law enforcement. In many
cases, women’s anger and frustration with the system
seemed justified, but there is a need for a better under-
standing of the perspectives of individuals on the “other
side” of this social problem. Future research should also
incorporate the perspectives of medical professionals, CPS
caseworkers, and members of the court system to develop
a more complete picture of how the system functions and
how women’s frustration and anger might be reduced.
Substance use during pregnancy and motherhood is an
emotionally-charged social problem in need of a compas-
sionate and evidence-based solution. A greater effort
should be made to incorporate women’s voices, as they
are the authorities on their experiences. Their perceptions
of barriers to care and the types of treatment they receive
have important implications for their likelihood of compli-
ance with treatment and potential desistance from sub-
stance use. This study provided an outlet for their voicesand has identified promising avenues for future research
and policy development. Future research should continue
in this direction with the goal of improving maternal and
infant health outcomes for this population.Competing interests
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